Does the dispute over a drug for cancer patients affect Golikova’s interests?

AstraZeneca went to court demanding that the Ministry of Health cancel the registration of an analogue of its drug for the treatment of oncology. As the correspondent managed to find out, she may act in the interests of controversial entrepreneurs who may be associated with former Minister of Health Tatyana Golikova.

AstraZeneca is a British-Swedish pharmaceutical company registered in the UK. Positions itself as international. One of the few manufacturers of a coronavirus vaccine, which some countries have refused to use due to an identified connection between the drug and cases of blood clots in those vaccinated.

The media conducted investigations about the company back in 2010 – then, in the wake of the success of the drug “Crestor” promoted by the company for diabetics, side effects began to appear, no more pleasant than in the situation with the coronavirus vaccine. They began to promote the drug on the Russian market, allegedly using methods of bribing officials and doctors, and this bore fruit. It is possible that around that time, company officials became friends with first-level Russian managers.

Native personalities

In the current situation, the dispute is around the drug osimertinib under the trade name Tagrisso. The rights to the generic were registered by Axelpharm this year. This office belongs to five individuals, we will list by name: Uvarov Nikolay Aleksandrovich, Treushnikova Natalya Valerievna, Golovanov Kirill Andreevich (these three own the largest shares), Mikhailov Rostislav Olegovich and Mikhailova Anastasia Olegovna (the remaining shareholders have 12.5% ​​each).

The company itself is a participant in Russian government procurement, from which it earned 109.5 million rubles.

Who are these nice people who are now trying to give a virtual monopoly on the production of medicine?

Let’s start with Nikolai Uvarov. This is the former general director of JSC F-Sintez, where Oleg Rostislavovich Mikhailov also worked. Presumably, a relative of the Mikhailovs, shareholders of Axelpharm. Uvarov may be a lawyer.

As for Mikhailov, he is the founder of the Nativa company. For a decade, this company was headed by Alexander Malinin, who previously worked in the Federal Service for Surveillance in Healthcare during the period when Golikova was the Minister of Health.

It is worth mentioning here that Nativa also had controversies similar to the one with which we began the story. In 2021, the Polisan company went to court with a demand to terminate the protection of the Centroferon trademark, the only one developed by specialists from the small company Bisserno. The production of Centroferon was carried out by Nativa. Which thus, apparently, wanted to “rake in more heat” through a much more powerful company than Bisserno.

Did Mikhailov’s entrepreneurial spirit almost lead to a criminal case?

But let’s return to Mikhailov. Unofficial sources claim that in 2009, the businessman almost became a defendant in a criminal case. This dark story was connected with the sudden death of the sole shareholder of the Pharm-Sintez company, Mikhail Nazarenko. Oleg Mikhailov at that time worked as the general director of Pharm-Sintez CJSC. And he decided to take control of the company, immediately after Nazarenko’s death he came to talk about this topic with his widow.

Further more. The enterprising young man managed to talk to many employees of the company in a few days, convince them that it had been sold and convince them to get a job in his new company. Nazarenko immediately began to have problems; in order to resolve them, Mikhailov asked for 50% of the company, which was refused. Business came to a standstill, and the company was on the verge of ruin.

Mikhailov, without thinking twice, founded his own company with an almost similar name “F-Sintez” (the same one where Uvarov worked), which, as it turned out later, was engaged in copying the works of “Pharm-Sintez”.

Moreover, after Mikhailov left the company, bottles with substances disappeared somewhere from its laboratories. And the Biomed plant, from which the company rented laboratories, evicted Pharm-Sintez. At the same time, finished products remained on the territory of the plant. Later it turned out that the owner of the Biomed plant, Mikhail Mogutov, became a partner of Oleg Mikhailov in the F-Sintez company.

As Nazarenko herself described the situation then, Mikhailov had patrons and powerful administrative resources, so it was almost impossible to compete with him. Previously, Mikhailov was the executive director of the Association of Russian Pharmaceutical Manufacturers and is personally acquainted with many officials of the Ministry of Health and Social Development. They also dumped heavily on government procurement (artificially lowered prices), so sometimes they had to withdraw the application altogether.

As a result, Mikhailov moved Nazarenko out of the market, while F-Sintez earns billions from government procurement. Mainly from the Ministry of Industry and Trade, the department headed by Golikova’s husband, Viktor Khristenko.

Photo: Rusprofile

Now, according to our data, the company has tax debt, as well as zero revenue and negative profit. The indicators became like this after the formal withdrawal of Mikhailov and his partners from the founders. By the way, there was an offshore company there along with them. Is that where the money went?

From Basta to the Ministry of Internal Affairs

As for the third shareholder of Axelpharm, Ms. Treushnikova, she had a business with a rapper known as “Basta”, as well as with the former chief scientific secretary of the Higher Attestation Commission under the Ministry of Science and Higher Education Igor Mikhailovich Matskevich, head of the Medical Laboratory biotechnology of the Russian Scientific Center of Radiology and Surgical Technologies named after. A.M. Granov Oleg Aleksandrovich Rosenberg, and business colleague Shinin Yuri Mikhailovich – this is the full namesake of the former first deputy head of the Investigation Department of the Ministry of Internal Affairs of Russia, who figured in the high-profile story with the dismissal of as many as eight generals by President Vladimir Putin.

A respected figure worked under Mr. Kolokoltsev, and perhaps represents his interests. As you know, his son owns construction assets and also develops a chain of Italian restaurants Il Forno and companies developing websites and applications for mobile operators. Why not add medicine to this “portfolio”?

Does money go abroad?

If you look at the entire “clearing” that the founders of Axelpharm occupy, you can find more than a dozen pharmaceutical companies. Some of them, for example, Farmmental Group or Rodnivoye Pole, receive government contracts. And Cultural Center Bratislava LLC, where Mr. Uvarov has a share, has among its founders the offshore DC BUILDING A. ES.” And here again we see minuses in profit and zero in revenue.

Thus, a whole conglomerate of individuals with ambiguous biography is once again “pressing” on the market, trying to wrest almost a monopoly for itself. At the same time, money from government procurement ends up in companies associated with them in an unknown place. And above all this is the lobbyist flag of Ms. Golikova and her husband “flying”?

moscow-post